What are the CDC Advisory Committee on Immunization Practices (ACIP) guidelines for routine pneumococcal vaccinations?

Updated: Jul 16, 2019
  • Author: Rodrigo Hasbun, MD, MPH; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

The ACIP recommends administration of 13-valent pneumococcal polysaccharide-protein conjugate vaccine as part of routine childhood immunization. [50] The ACIP recommends targeted use of the 23-valent pneumococcal polysaccharide vaccine (PPSV23, formerly PPV23) in children aged 2-18 years with underlying medical conditions that increase the risk of pneumococcal disease or complications. Vaccination against measles and mumps effectively eliminates aseptic meningitis syndrome caused by these pathogens. In September 2014, the CDC recommended that all adults aged 65 years or older receive both PCV13 (13-valent pneumococcal conjugate vaccine) and PPSV23 (23-valent pneumococcal polysaccharide vaccine) as part of routine vaccination. [51]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!